Longevity Health Holdings, Inc. XAGE
0.16
0.00
0.00%
as of 25 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow XAGE
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
142.66% | 130.54% | 127.68% | 109.80% | |
| (199.84%) | (359.56%) | (274.36%) | (286.02%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
147.83% | 117.75% | 97.61% | 77.54% | |
Average Days of Receivables |
87.26 | 6.96 | 9.91 | 4.22 | |
Free Cash Flow per Share |
(2.23) | (2.34) | (1.61) | (0.99) | |
Free Cash Flow |
(3.84) | (3.34) | (3.06) | (2.45) | |
Capital Expenditures |
(0.04) | (0.01) | — | — | |
Piotroski F-Score |
1.00 | 3.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
132.31% | 64.52% | 46.52% | 28.27% | |
Accounts Receivable Turnover |
5.13 | 11.17 | 8.06 | 8.98 | |
Accounts Payable Turnover |
0.15 | 0.19 | 0.15 | 0.14 | |
Inventory Turnover |
1.11 | 1.53 | 0.69 | 0.78 | |
Average Days of Payables |
2,479.16 | 2,005.43 | 2,515.23 | 2,659.04 | |
Days of Inventory on Hand |
602.33 | 429.65 | 366.35 | 320.10 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
57.81% | 41.24% | 36.09% | 29.19% | |
Selling, General and Administrative Expense of Revenue |
395.44% | 383.44% | 405.40% | 369.75% | |
Share Based Compensation of Revenue |
52.50% | 36.22% | 40.34% | 36.06% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.66 | 0.48 | 0.45 | 0.36 | |
Depreciation/Fixed assets |
1.85 | 2.12 | 2.04 | 1.98 | |
Capex/Depreciation |
(0.21) | (0.07) | 0.00 | 0.00 | |
Revenue per Share |
0.85 | 1.34 | 0.94 | 0.68 | |
Operating CF per Share |
(2.20) | (2.33) | (1.61) | (0.99) | |
Capex per Share |
(0.03) | (0.01) | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.01 | 0.00 | 0.00 | |
Net Profit Margin |
(393.61%) | (360.99%) | (380.71%) | (404.81%) |
Columns are period end dates